Lv11
50 积分 2021-10-15 加入
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
4小时前
已关闭
180P Preclinical evaluation of the novel TEAD inhibitor ODM-212
2个月前
已完结
Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI Disrupter
7个月前
已完结
207 (PB195): Evaluating the Use of Merlin-YAP Dual-label Immunohistochemistry for Predicting Response to TEAD Inhibitor VT3989
1年前
已关闭
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
1年前
已完结
Targeting the Hippo pathway in cancer
1年前
已完结
皖公网安备34019202002308
